{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:08:55Z","timestamp":1786975735461,"version":"build-2736575974"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi251146-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The Daraja randomized clinical trial was a linkage case management intervention designed to improve HIV care engagement. Understanding the economic value of this type of case management intervention is essential to decision-makers in resource-constrained settings seeking to minimize HIV-related morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251146-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the cost-effectiveness of Daraja compared with enhanced standard care from the Tanzania Ministry of Health and societal perspectives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251146-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective economic evaluation was conducted alongside the Daraja randomized clinical trial at 20 hospitals in Northwestern Tanzania from March 2019 to May 2023. Participants were patients hospitalized with HIV randomly assigned 1:1 to receive either the Daraja intervention or enhanced standard care and were followed up for 12 months through March 2023. Data were analyzed from May 2024 to March 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251146-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>The Daraja intervention group received up to 5 sessions conducted by a social worker at the hospital, in the home, and in the HIV clinic over a 3-month period. The enhanced standard care group received predischarge HIV counseling and assistance in scheduling an HIV clinic appointment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251146-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the cost per disability-adjusted life-year (DALY) averted for Daraja vs standard care, assessed from Ministry of Health and societal perspectives at 3 months (intervention) and 12 months (intervention plus follow-up).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251146-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 500 participants, the mean (SD) age was 37 [12] years, and 384 participants (77%) were female. Participants in the intervention group incurred more costs from the Tanzanian Ministry of Health perspective over the 3-month intervention period ($43.4 vs $24.0; difference, $19.4 [95% CI, $9.2 to $29.6]) and over the 12-month observation period ($101.6 vs $78.2; difference, $23.4 [95% CI, $8.0 to $38.9]). From the societal perspective, Daraja incurred more costs than standard care at 3 months ($72.4 vs $47.4; difference, $25.0 [95% CI, $2.0 to $48.0]) but not 12 months ($182.7 vs $160.5; difference, $22.2 [95% CI, \u2212$16.4 to 60.8]). DALYs were lower for Daraja participants at both the 3-month (1.2 [95% CI, 1.1 to 1.2] DALYs averted, annualized) and 12-month (1.1 [95% CI, 1.3 to 3.7] DALYs averted) time points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251146-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this economic evaluation of the Daraja intervention, Daraja was more costly than standard care from both the Tanzanian Ministry of Health and societal perspectives; however, it was associated with improvements in DALYs. These findings suggest that Daraja has a high probability of being considered cost-effective from both economic perspectives.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.42105","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:00:50Z","timestamp":1762358450000},"page":"e2542105","source":"Crossref","is-referenced-by-count":1,"title":["Cost-Effectiveness of Linkage Case Management for Hospitalized People With HIV"],"prefix":"10.1001","volume":"8","author":[{"given":"Megan","family":"Willkens","sequence":"first","affiliation":[{"name":"Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Issarow","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey","family":"Kisigo","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ayieko","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick","family":"Deogratias","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rutachunzibwa","sequence":"additional","affiliation":[{"name":"Ministry of Health, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Kabakama","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Grosskurth","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elialilia","family":"Okello","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Metsch","sequence":"additional","affiliation":[{"name":"Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi","family":"Kapiga","sequence":"additional","affiliation":[{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Hee","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Peck","sequence":"additional","affiliation":[{"name":"Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York"},{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"},{"name":"Department of Medicine, Weill Bugando School of Medicine, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"4","key":"zoi251146r3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11294-019-09754-3","article-title":"Effect of HIV\/AIDS on economic growth in sub-Saharan Africa: recent evidence.","volume":"25","author":"Nketiah-Amponsah","year":"2019","journal-title":"Int Adv Econ Res"},{"issue":"3","key":"zoi251146r4","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1016\/S2352-3018(21)00329-5","article-title":"Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis.","volume":"9","author":"Ford","year":"2022","journal-title":"Lancet HIV"},{"issue":"5","key":"zoi251146r5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/QAI.000000000001107","article-title":"Linkage to primary care and survival after hospital discharge for HIV-infected adults in Tanzania: a prospective cohort study.","volume":"73","author":"Peck","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"zoi251146r6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12889-024-21231-z","article-title":"\u201cAshamed of being seen in an HIV clinic\u201d: a qualitative analysis of barriers to engaging in HIV care from the perspectives of patients and healthcare workers in the Daraja clinical trial.","volume":"25","author":"Okello","year":"2025","journal-title":"BMC Public Health"},{"issue":"7","key":"zoi251146r8","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1016\/S2352-3018(23)00109-1","article-title":"Ending AIDS deaths requires improvements in clinical care for people with advanced HIV disease who are seriously ill.","volume":"10","author":"Burke","year":"2023","journal-title":"Lancet HIV"},{"issue":"12","key":"zoi251146r9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jama.2024.2177","article-title":"Linkage case management and posthospitalization outcomes in people with HIV: the Daraja randomized clinical trial.","volume":"331","author":"Peck","year":"2024","journal-title":"JAMA"},{"key":"zoi251146r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106680","article-title":"A social worker intervention to reduce post-hospital mortality in HIV-infected adults in Tanzania (Daraja): study protocol for a randomized controlled trial.","volume":"113","author":"Kisigo","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"9","key":"zoi251146r13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40273-016-0400-5","article-title":"Economic evaluations of opioid use disorder interventions.","volume":"34","author":"Murphy","year":"2016","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"zoi251146r14","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jval.2020.12.023","article-title":"Economic evaluations of pharmacologic treatment for opioid use disorder: a systematic literature review.","volume":"24","author":"Onuoha","year":"2021","journal-title":"Value Health"},{"issue":"9","key":"zoi251146r16","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/j.1360-0443.2010.03001.x","article-title":"Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial.","volume":"105","author":"Polsky","year":"2010","journal-title":"Addiction"},{"key":"zoi251146r17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.drugalcdep.2016.01.021","article-title":"Cost-effectiveness of an internet-delivered treatment for substance abuse: data from a multisite randomized controlled trial.","volume":"161","author":"Murphy","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"zoi251146r18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/add.13807","article-title":"Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.","volume":"112","author":"Murphy","year":"2017","journal-title":"Addiction"},{"issue":"2","key":"zoi251146r19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.7326\/M18-0227","article-title":"Cost-effectiveness of buprenorphine-naloxone versus extended-release naltrexone to prevent opioid relapse.","volume":"170","author":"Murphy","year":"2019","journal-title":"Ann Intern Med"},{"key":"zoi251146r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108835","article-title":"Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release.","volume":"141","author":"Jalali","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"zoi251146r21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.annemergmed.2024.10.001","article-title":"Cost-effectiveness of implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder.","volume":"85","author":"Lu","year":"2025","journal-title":"Ann Emerg Med"},{"issue":"7","key":"zoi251146r22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/00005650-199907000-00006","article-title":"Accuracy of self-reported health services use and patterns of care among urban older adults.","volume":"37","author":"Wallihan","year":"1999","journal-title":"Med Care"},{"issue":"2","key":"zoi251146r23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1077558705285298","article-title":"Self-reported utilization of health care services: improving measurement and accuracy.","volume":"63","author":"Bhandari","year":"2006","journal-title":"Med Care Res Rev"},{"issue":"2","key":"zoi251146r24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/oxfordjournals.aje.a115129","article-title":"Agreement between questionnaire data and medical records: the evidence for accuracy of recall.","volume":"129","author":"Harlow","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"9","key":"zoi251146r25","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/0895-4356(96)00143-6","article-title":"Comparison of self-reported and medical record health care utilization measures.","volume":"49","author":"Roberts","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"zoi251146r26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/00005650-199205000-00003","article-title":"Patients as reliable reporters of medical care process. Recall of ambulatory encounter events.","volume":"30","author":"Brown","year":"1992","journal-title":"Med Care"},{"issue":"7","key":"zoi251146r27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/JOM.0b013e3181a86671","article-title":"How accurate are self-reports: analysis of self-reported health care utilization and absence when compared with administrative data.","volume":"51","author":"Short","year":"2009","journal-title":"J Occup Environ Med"},{"issue":"1","key":"zoi251146r28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13690-022-00860-z","article-title":"A systematic literature review of disability weights measurement studies: evolution of methodological choices.","volume":"80","author":"Charalampous","year":"2022","journal-title":"Arch Public Health"},{"issue":"6","key":"zoi251146r29","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures.","volume":"11","author":"Pichon-Riviere","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"8","key":"zoi251146r30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","article-title":"Country-level cost-effectiveness thresholds: initial estimates and the need for further research.","volume":"19","author":"Woods","year":"2016","journal-title":"Value Health"},{"key":"zoi251146r31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.eclinm.2019.04.006","article-title":"Cost-effectiveness of HIV prevention interventions in Sub-Saharan Africa: a systematic review.","volume":"10","author":"Sarkar","year":"2019","journal-title":"EClinicalMedicine"},{"issue":"4","key":"zoi251146r32","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf175","article-title":"Interventions to support people with HIV following hospital discharge: a systematic review.","volume":"12","author":"Ford","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"zoi251146r33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost-effectiveness thresholds: pros and cons.","volume":"94","author":"Bertram","year":"2016","journal-title":"Bull World Health Organ"},{"issue":"1","key":"zoi251146r34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/ije\/dyy203","article-title":"HIV testing and counselling couples together for affordable HIV prevention in Africa.","volume":"48","author":"Wall","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"4","key":"zoi251146r35","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/S2352-3018(15)00016-8","article-title":"Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis.","volume":"2","author":"Smith","year":"2015","journal-title":"Lancet HIV"},{"issue":"2","key":"zoi251146r36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030216","article-title":"Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050.","volume":"7","author":"Granich","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"zoi251146r37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/heapol\/czs140","article-title":"Cost-effectiveness of provider-based HIV partner notification in urban Malawi.","volume":"29","author":"Rutstein","year":"2014","journal-title":"Health Policy Plan"},{"issue":"3","key":"zoi251146r38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/0962280210395740","article-title":"Review of inverse probability weighting for dealing with missing data.","volume":"22","author":"Seaman","year":"2013","journal-title":"Stat Methods Med Res"},{"key":"zoi251146r11","volume-title":"Cost-Effectiveness in Health and Medicine","author":"Neumann","year":"2017","edition":"2nd ed"},{"key":"zoi251146r12","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199685028.001.0001","volume-title":"Economic Evaluation in Clinical Trial","author":"Glick","year":"2014"},{"key":"zoi251146r15","volume-title":"Strategic Planning","author":"Steiner","year":"2010"},{"key":"zoi251146r1","unstructured":"World Health Organization. The Global Health Observatory: HIV. Updated 2024. Accessed February 17, 2025. https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids"},{"key":"zoi251146r2","unstructured":"UNAIDS. Eastern and Southern Africa regional profile\u20142024 global AIDS update. Updated 2024. Accessed February 17, 2025. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2024-unaids-global-aids-update-eastern-southern-africa_en.pdf?t"},{"key":"zoi251146r7","unstructured":"World Health Organization. Providing care to people with advanced HIV disease who are seriously ill. Updated 2023. Accessed February 17, 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240068650"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2840993\/willkens_2025_oi_251146_1761766588.59928.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:00:52Z","timestamp":1762358452000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2840993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.42105","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}